Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the detailed record of transactions filed by Viking Global Performance Llc. Director active across 2 companies, notably Editas Medicine, Inc.. Cumulatively, 19 filings have been recorded. Breakdown: 14 buys · 1 sell. Total volume traded: €1m. Activity tracked since 22 June 2023. The latest transaction was filed on 22 June 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Viking Global Performance Llc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
VIKING GLOBAL PERFORMANCE LLC has filed 19 disclosures in total. Across the 19 sampled recent disclosures, the reported volumes cover purchases of EUR 0 and sales of EUR 1000542, with a date range from 2016-02-08 to 2023-06-26. The companies involved are Editas Medicine, Inc. and Roivant Sciences Ltd., and the largest filing shown in the recent sample is a sale of EUR 1000542.022454619 in Roivant Sciences Ltd. on 2023-06-26.